Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Lodelcizumab Biosimilar – Anti-PCSK9 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Lodelcizumab Biosimilar - Anti-PCSK9 mAb - Research Grade |
|---|---|
| Source | CAS 1355338-54-3 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Lodelcizumab,LGT209,NVP-LGT209,PCSK9,anti-PCSK9 |
| Reference | PX-TA1320 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Lodelcizumab Biosimilar - Anti-PCSK9 mAb - Research Grade
General information on Anti-PCSK9[Homo sapiens] (Lodelcizumab) Monoclonal Antibody
Lodelcizumab is used for the treatment of hypercholesterolemia.
Lodelcizumab Biosimilar - Anti-PCSK9 mAb binds to Human PCSK9 recombinant protein in indirect ELISA Assay
Immobilized Human PCSK9 recombinant protein (cat. No.PX-P5124) at 0.5µg/mL (100µL/well) can bind to Lodelcizumab Biosimilar - Anti-PCSK9 mAb (cat. No.PX-TA1320) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Antigen
Human PCSK9 recombinant protein
PX-P5124 110€
Antigen
PCSK9, C-His, recombinant protein
PX-P5877 420€
ELISA
Lodelcizumab ELISA Kit
KPTX269 1179€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.